Impact of liposome bupivacaine on the adequacy of pain management and patient experiences following aesthetic surgery: Results from an observational study.
about
A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (μ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty.Multimodal Analgesia in Breast Surgical Procedures: Technical and Pharmacological Considerations for Liposomal Bupivacaine Use.
P2860
Impact of liposome bupivacaine on the adequacy of pain management and patient experiences following aesthetic surgery: Results from an observational study.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Impact of liposome bupivacaine ...... s from an observational study.
@ast
Impact of liposome bupivacaine ...... s from an observational study.
@en
type
label
Impact of liposome bupivacaine ...... s from an observational study.
@ast
Impact of liposome bupivacaine ...... s from an observational study.
@en
prefLabel
Impact of liposome bupivacaine ...... s from an observational study.
@ast
Impact of liposome bupivacaine ...... s from an observational study.
@en
P2093
P2860
P1476
Impact of liposome bupivacaine ...... s from an observational study.
@en
P2093
Evan Sorokin
Farzad R Nahai
Holly Wall
Kevin Smith
Mark Brzezienski
Michael C Edwards
Richard Scranton
Simeon Wall
Stephan Finical
P2860
P356
10.4172/PLASTIC-SURGERY.1000904
P407
P577
2015-01-01T00:00:00Z